FINWIRES · TerminalLIVE
FINWIRES

Innovent Biologics' Application for Gastric Cancer Drug Accepted in China

By

Innovent Biologics' (HKG:1801) new drug application for arcotatug tavatecan was accepted by China's National Medical Products Administration and granted priority review, according to a Thursday Hong Kong bourse filing.

The application was submitted after an international multi-center phase 3 clinical study of the drug reached the primary endpoint after completing the per-protocol first interim analysis.

The drug demonstrated excellent efficacy and a tolerable safety profile in the treatment of advanced gastric cancer.

Related Articles

Asia

Super-Dragon Engineering Plastics Completes Registration Change

Super-Dragon Engineering Plastics (SHE:301131) completed its industrial and commercial registration change and received a new business license from the Guangzhou Municipal Administration for Market Regulation.The company specializes in engineering plastics, synthetic resins, bio-based materials and high-performance composites, according to a Thursday filing with the Shenzhen bourse.Shares of the industrial supplies company closed 2% lower Thursday.

$SHE:301131
Asia

Hong Fok Repurchases More Shares

Hong Fok (SGX:H30) bought back 198,000 shares in the open market on Thursday for around SG$192,874, according to a same-day after-market filing with the Singapore Exchange.To date, the property investment company has repurchased over 3.6 million shares under its current buyback program.

$SGX:H30
Asia

Physics Wallah Shifts Student Lending Strategy to NBFC Partnerships; Shares Jump 15%

Physics Wallah (NSE:PWL, BOM:544609) has revised its student lending strategy and partnered with multiple regulated non-banking financial companies to facilitate loans for students, according to a Thursday filing on Indian bourses.The move reverses the company's earlier plan to expand lending through its wholly owned subsidiary FinZ Finance, in which it had recently announced an investment of about 1.20 billion rupees.Physics Wallah said the new model is expected to reduce balance-sheet and credit risks. The company added that it will continue to operate as a technology platform connecting students with lending partners.The future strategic direction of FinZ Finance will be decided later, subject to board and regulatory approvals, Physics Wallah said in the filing.Shares of the company jumped nearly 15% in recent trade.

$BOM:544609$NSE:PWL